Alzheimer’s costs expected to increase by $20 billion this year
By
Lois A. Bowers
Mar 21, 2018
The national cost of caring for those with Alzheimer’s and other dementias is projected to increase $20 billion this year compared with last year, totaling more than $277 billion in 2018, according...
One new law requires operators to provide tech for residents; another supports access to dementia screening...
By
Kimberly Bonvissuto
Oct 07, 2021
Assisted living operators in California will be required to provide video conferencing devices for residents under legislation signed into law on Monday. Another new law provides older adults in the Golden...
Dementia testing: Older adults see value, but few have undergone it
By
Kimberly Bonvissuto
Jul 24, 2023
The majority of older adults see benefit in dementia screening tests, but most have not been tested in the past year, and a majority never have been screened, according to the results of a new poll.
‘Alzheimer’s crisis’ intersecting with direct care workforce challenges, association says
By
Kimberly Bonvissuto
Mar 16, 2023
The nation is facing an “Alzheimer’s crisis” as the number of older adults in whom the disease is diagnosed continues to increase amid a shortage of direct care workers, according to the Alzheimer’s...
Financial burden of dementia poses challenges for older adults, caregivers, payers: researchers
By
Kimberly Bonvissuto
Feb 09, 2024
The growing population of older adults brings with it an increased prevalence of Alzheimer’s disease and related dementias. Two new papers look at the increasing financial burden on people living with...
Legislation aims to ensure ‘fair and accurate’ Alzheimer’s treatment coverage decisions
By
Kimberly Bonvissuto
Nov 21, 2023
Federal legislation that would prevent the federal government from imposing wide-reaching coverage restrictions on Alzheimer’s treatments was reintroduced last week, providing “fair and accurate”...
Should residents’ access to Alzheimer’s drug be restricted?
By
Lois A. Bowers
Jan 18, 2022
You have until Feb. 10 to share your comments with CMS about its recent proposal related to Alzheimer’s drug aducanumab (Aduhelm).
NIH asks for $414.4 million more for Alzheimer’s research
By
Lois A. Bowers
Aug 01, 2016
The National Institutes of Health will need $414.4 million more than its base appropriation for Alzheimer’s disease and related dementias in fiscal year 2018 if it is to meet the research goals of...
Decision-making on antipsychotic medication use in assisted living needs system-level perspective: study
By
Kimberly Bonvissuto
Jan 25, 2023
Decisions on administering as-needed antipsychotic medications in assisted living/ residential care communities are based on attitudes, underlying morality and perceived expertise, requiring a system-level...
Senior living deserves dedicated funding source for COVID-19 testing, tracing, PPE: Alzheimer’s Association
By
Kimberly Bonvissuto
Apr 02, 2021
Assisted living communities should have a dedicated funding source for COVID-19 testing, tracing and personal protective equipment, the Alzheimer’s Association said in testimony submitted to a senate...